Epidemiology and etiology of non-Hodgkin lymphoma – a review

References

• ESHN Jaffe, Stein, H, Vardiman, JW, editors. Pathology and genetics of tumours of hematopoietic and lymphoid tissues. Lyon: IARC Press; 2001.
   Google Scholar
• Chiu BC, Weisenburger DD. An update of the epidemiology of non-Hodgkin's lymphoma. Clin Lymphoma 2003; 4: 161–8
   PubMedGoogle Scholar
• A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987–94.
   PubMed Web of Science ®Google Scholar
• Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503–11
   PubMed Web of Science ®Google Scholar
• Cancer IAfRo. Globocan. Cancer Incidence, Mortality and Prevalence Worldwide. In: J Ferlay, Bray, P, Pisani, P, Parkin, DM, editors. Lyon: IARC Press; 2001.
   Google Scholar
• Cancer Incidence in Sweden 2003. Stockholm: 2005.
   Google Scholar
• Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533–43
   PubMed Web of Science ®Google Scholar
• Baris D, Zahm SH. Epidemiology of lymphomas. Curr Opin Oncol 2000; 12: 383–94
   PubMed Web of Science ®Google Scholar
• Coleman, MP, Esteve, J, Damiecki, P, Arslan, A, Renard, H. Trends in cancer incidence and mortality. IARC Sci Publ 1993;1–806.
   PubMedGoogle Scholar
• Hakulinen T, Andersen A, Malker B, Pukkala E, Schou G, Tulinius H. Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries. Acta Pathol Microbiol Immunol Scand Suppl 1986; 288: 1–151
   PubMedGoogle Scholar
• Zheng T, Mayne ST, Boyle P, Holford TR, Liu WL, Flannery J. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935–1988. Cancer 1992; 70: 840–9
   PubMed Web of Science ®Google Scholar
• Devesa SS, Fears T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res 1992; 52: S5432–40
   PubMed Web of Science ®Google Scholar
• Registries, AoNC. NORDCAN. Copenhagen: 2004.
   Google Scholar
• Clarke CA, Glaser SL. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 2002; 94: 2015–23
   PubMed Web of Science ®Google Scholar
• Herrinton LJ. Epidemiology of the Revised European-American Lymphoma Classification subtypes. Epidemiol Rev 1998; 20: 187–203
   PubMedGoogle Scholar
• Banks PM. Changes in diagnosis of non-Hodgkin's lymphomas over time. Cancer Res 1992; 52: S5453–5
   PubMed Web of Science ®Google Scholar
• Hartge P, Devesa SS. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence. Cancer Res 1992; 52: S5566–9
   PubMed Web of Science ®Google Scholar
• Wigzell H. Vårt fantastiska immunförsvar. Liber, Stockholm 1987
   Google Scholar
• Offit K, Wong G, Filippa DA, Tao Y, Chaganti RS. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Clinical correlations. Blood 1991; 77: 1508–15
   PubMed Web of Science ®Google Scholar
• Ye BH. BCL-6 in the pathogenesis of non-Hodgkin's lymphoma. Cancer Invest 2000; 18: 356–65
   PubMed Web of Science ®Google Scholar
• Smith, MT, Skibola, CF, Allan, JM, Morgan, GJ. Causal models of leukaemia and lymphoma. IARC Sci Publ 2004;373–92.
   PubMedGoogle Scholar
• Filipovich AH, Mathur A, Kamat D, Shapiro RS. Primary immunodeficiencies: Genetic risk factors for lymphoma. Cancer Res 1992; 52: S5465–7
   PubMed Web of Science ®Google Scholar
• Aboulafia DM, Pantanowitz L, Dezube BJ. AIDS-related non-Hodgkin lymphoma: Still a problem in the era of HAART. AIDS Read 2004; 14: 605–17
   PubMedGoogle Scholar
• International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000;92:1823–30.
   PubMed Web of Science ®Google Scholar
• Killebrew D, Shiramizu B. Pathogenesis of HIV-associated non-Hodgkin lymphoma. Curr HIV Res 2004; 2: 215–21
   PubMedGoogle Scholar
• Opelz G, Dohler B. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant 2004; 4: 222–30
   PubMed Web of Science ®Google Scholar
• Andreone P, Gramenzi A, Lorenzini S, Biselli M, Cursaro C, Pileri S, et al. Posttransplantation lymphoproliferative disorders. Arch Intern Med 2003; 163: 1997–2004
   PubMedGoogle Scholar
• Zhu K, Levine RS, Gu Y, Brann EA, Hall I, Caplan LS, et al. Non-Hodgkin's lymphoma and family history of malignant tumors in a case-control study (United States). Cancer Causes Control 1998; 9: 77–82
   PubMed Web of Science ®Google Scholar
• Paltiel O, Schmit T, Adler B, Rachmilevitz EA, Polliack A, Cohen A, et al. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: Results and limitations of a registry-linked study. Cancer 2000; 88: 2357–66
   PubMed Web of Science ®Google Scholar
• Chiu BC, Weisenburger DD, Zahm SH, Cantor KP, Gapstur SM, Holmes F, et al. Agricultural pesticide use, familial cancer, and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2004; 13: 525–31
   PubMed Web of Science ®Google Scholar
• Goldin LR, Pfeiffer RM, Gridley G, Gail MH, Li X, Mellemkjaer L, et al. Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 2004; 100: 1902–8
   PubMed Web of Science ®Google Scholar
• Chang ET, Smedby KE, Hjalgrim H, Porwit-MacDonald A, Roos G, Glimelius B, et al. Family history of hematopoietic malignancy and risk of lymphoma. J Natl Cancer Inst 2005; 97: 1466–74
   PubMed Web of Science ®Google Scholar
• Goldin LR, Pfeiffer RM, Li X, Hemminki K. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: Results from the Swedish Family-Cancer Database. Blood 2004; 104: 1850–4
   PubMed Web of Science ®Google Scholar
• Mainou-Fowler T, Dickinson AM, Taylor PR, Mounter P, Jack F, Proctor SJ, et al. Tumour necrosis factor gene polymorphisms in lymphoproliferative disease. Leuk Lymphoma 2000; 38: 547–52
   PubMed Web of Science ®Google Scholar
• Vasku JA, Vasku A, Goldbergova M, Vasku V. Heterozygote AG variant of -596 A/G IL-6 gene polymorphism is a marker for cutaneous T-cell lymphoma (CTCL). Clin Immunol 2004; 113: 256–60
   PubMedGoogle Scholar
• Hishida A, Matsuo K, Tajima K, Ogura M, Kagami Y, Taji H, et al. Polymorphisms of p53 Arg72Pro, p73 G4C14-to-A4T14 at exon 2 and p21 Ser31Arg and the risk of non-Hodgkin's lymphoma in Japanese. Leuk Lymphoma 2004; 45: 957–64
   PubMed Web of Science ®Google Scholar
• Hishida A, Matsuo K, Hamajima N, Ito H, Ogura M, Kagami Y, et al. Polymorphism in the hMSH2 gene (gIVS 12-6T– > C) and risk of non-Hodgkin lymphoma in a Japanese population. Cancer Genet Cytogenet 2003; 147: 71–4
   PubMedGoogle Scholar
• Soucek P, Sarmanova J, Kristensen VN, Apltauerova M, Gut I. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Int Arch Occup Environ Health 2002; 75(Suppl)S86–92
   Google Scholar
• Skibola CF, Forrest MS, Coppede F, Agana L, Hubbard A, Smith MT, et al. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 2004; 104: 2155–62
   PubMed Web of Science ®Google Scholar
• Caporaso N, Marti GE, Goldin L. Perspectives on familial chronic lymphocytic leukemia: Genes and the environment. Semin Hematol 2004; 41: 201–6
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lan Q, Rothman N, Zhu Y, Zahm SH, Wang SS, et al. A putative exonic splicing polymorphism in the BCL6 gene and the risk of non-Hodgkin lymphoma. J Natl Cancer Inst 2005; 97: 1616–8
   PubMed Web of Science ®Google Scholar
• Niederman JC, Evans AS, Subrahmanyan L, McCollum RW. Prevalence, incidence and persistence of EB virus antibody in young adults. N Engl J Med 1970; 282: 361–5
   PubMed Web of Science ®Google Scholar
• Oertel SH, Riess H. Immunosurveillance, immunodeficiency and lymphoproliferations. Recent Results Cancer Res 2002; 159: 1–8
   PubMedGoogle Scholar
• Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004; 4: 757–68
   PubMed Web of Science ®Google Scholar
• Cancer IAfRo. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Herpesvirus 8. In: IARC Monographs on the evaluation of carcinogenic risks in humans. Lyon: 1997.
   Google Scholar
• Judde JG, Lacoste V, Briere J, Kassa-Kelembho E, Clyti E, Couppie P, et al. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. J Natl Cancer Inst 2000; 92: 729–36
   PubMed Web of Science ®Google Scholar
• Jeang KT, Giam CZ, Majone F, Aboud M. Life, death and tax: Role of HTLV-I oncoprotein in genetic instability and cellular transformation. J Biol Chem 2004; 279: 31991–4
   PubMed Web of Science ®Google Scholar
• Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: Systematic review and meta-analysis. Gastroenterology 2003; 125: 1723–32
   PubMed Web of Science ®Google Scholar
• Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S. B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: A systematic review. Int J Cancer 2004; 111: 1–8
   PubMed Web of Science ®Google Scholar
• Fiorilli M, Mecucci C, Farci P, Casato M. HCV-associated lymphomas. Rev Clin Exp Hematol 2003; 7: 406–23
   PubMedGoogle Scholar
• De Re V, De Vita S, Marzotto A, Rupolo M, Gloghini A, Pivetta B, et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 2000; 96: 3578–84
   PubMed Web of Science ®Google Scholar
• Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R. Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection. Aliment Pharmacol Ther 2005; 21: 653–62
   PubMed Web of Science ®Google Scholar
• Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol 2002; 55: 4–13
   PubMed Web of Science ®Google Scholar
• Butel JS, Vilchez RA, Jorgensen JL, Kozinetz CA. Association between SV40 and non-Hodgkin's lymphoma. Leuk Lymphoma 2003; 44(Suppl 3)S33–9
   Google Scholar
• Engels EA, Viscidi RP, Galloway DA, Carter JJ, Cerhan JR, Davis S, et al. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. J Natl Cancer Inst 2004; 96: 1368–74
   PubMed Web of Science ®Google Scholar
• Fisher SG, Fisher RI. The epidemiology of non-Hodgkin's lymphoma. Oncogene 2004; 23: 6524–34
   PubMed Web of Science ®Google Scholar
• Shivapurkar N, Harada K, Reddy J, Scheuermann RH, Xu Y, McKenna RW, et al. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002; 359: 851–2
   PubMed Web of Science ®Google Scholar
• Vilchez RA, Madden CR, Kozinetz CA, Halvorson SJ, White ZS, Jorgensen JL, et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002; 359: 817–23
   PubMed Web of Science ®Google Scholar
• Nakatsuka S, Liu A, Dong Z, Nomura S, Takakuwa T, Miyazato H, et al. Simian virus 40 sequences in malignant lymphomas in Japan. Cancer Res 2003; 63: 7606–8
   PubMed Web of Science ®Google Scholar
• MacKenzie J, Wilson KS, Perry J, Gallagher A, Jarrett RF. Association between simian virus 40 DNA and lymphoma in the United Kingdom. J Natl Cancer Inst 2003; 95: 1001–3
   PubMed Web of Science ®Google Scholar
• Montesinos-Rongen M, Besleaga R, Heinsohn S, Siebert R, Kabisch H, Wiestler OD, et al. Absence of simian virus 40 DNA sequences in primary central nervous system lymphoma in HIV-negative patients. Virchows Arch 2004; 444: 436–8
   PubMed Web of Science ®Google Scholar
• Brousset P, de Araujo V, Gascoyne RD. Immunohistochemical investigation of SV40 large T antigen in Hodgkin and non-Hodgkin's lymphoma. Int J Cancer 2004; 112: 533–5
   PubMed Web of Science ®Google Scholar
• Hernandez-Losa J, Fedele CG, Pozo F, Tenorio A, Fernandez V, Castellvi J, et al. Lack of association of polyomavirus and herpesvirus types 6 and 7 in human lymphomas. Cancer 2005; 103: 293–8
   PubMed Web of Science ®Google Scholar
• Schuler F, Dolken SC, Hirt C, Dolken MT, Mentel R, Gurtler LG, et al. No evidence for simian virus 40 DNA sequences in malignant non-Hodgkin lymphomas. Int J Cancer 2006; 118: 498–504
   PubMed Web of Science ®Google Scholar
• de Sanjose S, Shah KV, Domingo-Domenech E, Engels EA, Fernandez de Sevilla A, Alvaro T, et al. Lack of serological evidence for an association between simian virus 40 and lymphoma. Int J Cancer 2003; 104: 522–4
   PubMed Web of Science ®Google Scholar
• Rollison DE, Page WF, Crawford H, Gridley G, Wacholder S, Martin J, et al. Case-control study of cancer among US Army veterans exposed to simian virus 40-contaminated adenovirus vaccine. Am J Epidemiol 2004; 160: 317–24
   PubMed Web of Science ®Google Scholar
• Engels EA, Katki HA, Nielsen NM, Winther JF, Hjalgrim H, Gjerris F, et al. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst 2003; 95: 532–9
   PubMed Web of Science ®Google Scholar
• Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175–6
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267–71
   PubMed Web of Science ®Google Scholar
• Hussell T, Isaacson PG, Crabtree JE, Spencer J. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 1996; 178: 122–7
   PubMed Web of Science ®Google Scholar
• Isaacson PG. Update on MALT lymphomas. Best Pract Res Clin Haematol 2005; 18: 57–68
   PubMed Web of Science ®Google Scholar
• Goodlad JR, Davidson MM, Hollowood K, Ling C, MacKenzie C, Christie I, et al. Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland. Am J Surg Pathol 2000; 24: 1279–85
   PubMed Web of Science ®Google Scholar
• Wood GS, Kamath NV, Guitart J, Heald P, Kohler S, Smoller BR, et al. Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States. J Cutan Pathol 2001; 28: 502–7
   PubMed Web of Science ®Google Scholar
• Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F, et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004; 350: 239–48
   PubMed Web of Science ®Google Scholar
• Ferreri AJ, Guidoboni M, Ponzoni M, De Conciliis C, Dell'Oro S, Fleischhauer K, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 2004; 96: 586–94
   PubMed Web of Science ®Google Scholar
• La Vecchia C, Negri E, Franceschi S. Medical history and the risk of non-Hodgkin's lymphomas. Cancer Epidemiol Biomarkers Prev 1992; 1: 533–6
   PubMedGoogle Scholar
• Tavani A, La Vecchia C, Franceschi S, Serraino D, Carbone A. Medical history and risk of Hodgkin's and non-Hodgkin's lymphomas. Eur J Cancer Prev 2000; 9: 59–64
   PubMed Web of Science ®Google Scholar
• Vineis P, Crosignani P, Sacerdote C, Fontana A, Masala G, Miligi L, et al. Haematopoietic cancer and medical history: A multicentre case control study. J Epidemiol Community Health 2000; 54: 431–6
   PubMed Web of Science ®Google Scholar
• Askling J, Ekbom A. Risk of non-Hodgkin's lymphoma following tuberculosis. Br J Cancer 2001; 84: 113–5
   PubMedGoogle Scholar
• Leandro MJ, Isenberg DA. Rheumatic diseases and malignancy–is there an association?. Scand J Rheumatol 2001; 30: 185–8
   PubMed Web of Science ®Google Scholar
• Boffetta P, Gridley G, Lindelof B. Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden. J Invest Dermatol 2001; 117: 1531–7
   PubMed Web of Science ®Google Scholar
• Gelfand JM, Berlin J, Van Voorhees A, Margolis DJ. Lymphoma rates are low but increased in patients with psoriasis: Results from a population-based cohort study in the United Kingdom. Arch Dermatol 2003; 139: 1425–9
   PubMed Web of Science ®Google Scholar
• Mir-Madjlessi SH, Farmer RG, Easley KA, Beck GJ. Colorectal and extracolonic malignancy in ulcerative colitis. Cancer 1986; 58: 1569–74
   PubMed Web of Science ®Google Scholar
• Arseneau KO, Stukenborg GJ, Connors AF, Jr, Cominelli F. The incidence of lymphoid and myeloid malignancies among hospitalized Crohn's disease patients. Inflamm Bowel Dis 2001; 7: 106–12
   PubMed Web of Science ®Google Scholar
• Askling J, Brandt L, Lapidus A, Karlén P, Björkholm M, Löfberg R, et al. Risk of hematopoietic cancer in patients with inflammatory bowel disease. Gut 2005; 54: 617–22
   PubMed Web of Science ®Google Scholar
• Ehrenfeld M, Abu-Shakra M, Buskila D, Shoenfeld Y. The dual association between lymphoma and autoimmunity. Blood Cells Mol Dis 2001; 27: 750–6
   PubMed Web of Science ®Google Scholar
• Kauppi M, Pukkala E, Isomaki H. Elevated incidence of hematologic malignancies in patients with Sjogren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control 1997; 8: 201–4
   PubMed Web of Science ®Google Scholar
• Pertovaara M, Pukkala E, Laippala P, Miettinen A, Pasternack A. A longitudinal cohort study of Finnish patients with primary Sjogren's syndrome: Clinical, immunological, and epidemiological aspects. Ann Rheum Dis 2001; 60: 467–72
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Brito-Zeron P, Yague J, Akasbi M, Bautista R, Ruano M, et al. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome. Rheumatology (Oxford) 2005; 44: 89–94
   PubMed Web of Science ®Google Scholar
• Theander, E, Henriksson, G, Ljungberg, O, Mandl, T, Manthorpe, R, Jacobsson, LTH. Lymphoma and other malignancies in primary Sjögren's syndrome: A cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2005; Nov 10; [Epub ahead of print].
   PubMedGoogle Scholar
• Royer B, Cazals-Hatem D, Sibilia J, Agbalika F, Cayuela JM, Soussi T, et al. Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 1997; 90: 766–75
   PubMed Web of Science ®Google Scholar
• Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjogren's syndrome: A multicenter, retrospective, clinical study by the European Concerted Action on Sjogren's Syndrome. Arthritis Rheum 1999; 42: 1765–72
   PubMed Web of Science ®Google Scholar
• Smedby, KE, Hjalgrim, H, Askling, J, Chang, ET, Gregersen, H, Porwit-MacDonald, A, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 2005; In Press.
   Google Scholar
• Hakulinen T, Isomaki H, Knekt P. Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med 1985; 78: 29–32
   PubMed Web of Science ®Google Scholar
• Mellemkjaer L, Linet MS, Gridley G, Frisch M, Moller H, Olsen JH. Rheumatoid arthritis and cancer risk. Eur J Cancer 1996; 32A: 1753–7
   PubMed Web of Science ®Google Scholar
• Thomas E, Brewster DH, Black RJ, Macfarlane GJ. Risk of malignancy among patients with rheumatic conditions. Int J Cancer 2000; 88: 497–502
   PubMed Web of Science ®Google Scholar
• Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 2004; 50: 1740–51
   PubMed Web of Science ®Google Scholar
• Zhang Y, Holford TR, Leaderer B, Zahm SH, Boyle P, Morton LM, et al. Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women. Cancer Causes Control 2004; 15: 419–28
   PubMed Web of Science ®Google Scholar
• Franklin, J, Lunt, M, Bunn, D, Symmons, DP, Silman, AJ. Incidence of lymphoma in a large primary-care derived cohort of inflammatory polyarthritis. Ann Rheum Dis 2005, Oct 25; [Epub ahead of print]
   Google Scholar
• Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM. Tumor necrosis factor antagonist therapy and lymphoma development: Twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 2002; 46: 3151–8
   PubMed Web of Science ®Google Scholar
• Baecklund E, Ekbom A, Sparen P, Feltelius N, Klareskog L. Disease activity and risk of lymphoma in patients with rheumatoid arthritis: Nested case-control study. BMJ 1998; 317: 180–1
   PubMed Web of Science ®Google Scholar
• Kamel OW, Holly EA, van de Rijn M, Lele C, Sah A. A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis. J Rheumatol 1999; 26: 1676–80
   PubMedGoogle Scholar
• Adami J, Frisch M, Yuen J, Glimelius B, Melbye M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ 1995; 310: 1491–5
   PubMed Web of Science ®Google Scholar
• Frisch M, Hjalgrim H, Olsen JH, Melbye M. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med 1996; 125: 815–21
   PubMed Web of Science ®Google Scholar
• Levi F, Randimbison L, Te VC, La Vecchia C. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996; 74: 1847–50
   PubMed Web of Science ®Google Scholar
• McKenna DB, Doherty VR, McLaren KM, Hunter JA. Malignant melanoma and lymphoproliferative malignancy: Is there a shared aetiology?. Br J Dermatol 2000; 143: 171–3
   PubMed Web of Science ®Google Scholar
• Goggins WB, Finkelstein DM, Tsao H. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer 2001; 91: 874–80
   PubMed Web of Science ®Google Scholar
• Lens MB, Newton-Bishop JA. An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review. Ann Oncol 2005; 16: 460–5
   PubMed Web of Science ®Google Scholar
• Cartwright R, McNally R, Staines A. The increasing incidence of non-Hodgkin's lymphoma (NHL): The possible role of sunlight. Leuk Lymphoma 1994; 14: 387–94
   PubMed Web of Science ®Google Scholar
• Hughes AM, Armstrong BK, Vajdic CM, Turner J, Grulich AE, Fritschi L, et al. Sun exposure may protect against non-Hodgkin lymphoma: A case-control study. Int J Cancer 2004; 112: 865–71
   PubMed Web of Science ®Google Scholar
• Smedby KE, Hjalgrim H, Melbye M, Torrang A, Rostgaard K, Munksgaard L, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 2005; 97: 199–209
   PubMed Web of Science ®Google Scholar
• Norval M. Effects of solar radiation on the human immune system. J Photochem Photobiol B 2001; 63: 28–40
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D: A millenium perspective. J Cell Biochem 2003; 88: 296–307
   PubMed Web of Science ®Google Scholar
• Bernstein L, Ross RK. Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: Preliminary results from a case-control study in Los Angeles County. Cancer Res 1992; 52: S5510–5
   PubMed Web of Science ®Google Scholar
• Holly EA, Lele C, Bracci PM, McGrath MS. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 1999; 150: 375–89
   PubMed Web of Science ®Google Scholar
• McDuffie HH, Pahwa P, McLaughlin JR, Spinelli JJ, Fincham S, Dosman JA, et al. Non-Hodgkin's lymphoma and specific pesticide exposures in men: Cross-Canada study of pesticides and health. Cancer Epidemiol Biomarkers Prev 2001; 10: 1155–63
   PubMed Web of Science ®Google Scholar
• Lee WJ, Cantor KP, Berzofsky JA, Zahm SH, Blair A. Non-Hodgkin's lymphoma among asthmatics exposed to pesticides. Int J Cancer 2004; 111: 298–302
   PubMed Web of Science ®Google Scholar
• Grulich AE, Vajdic CM, Kaldor JM, Hughes AM, Kricker A, Fritschi L, et al. Birth order, atopy, and risk of non-Hodgkin lymphoma. J Natl Cancer Inst 2005; 97: 587–94
   PubMedGoogle Scholar
• Hagstromer L, Ye W, Nyren O, Emtestam L. Incidence of cancer among patients with atopic dermatitis. Arch Dermatol 2005; 141: 1123–7
   PubMedGoogle Scholar
• Lindelof B, Granath F, Tengvall-Linder M, Ekbom A. Allergy and cancer. Allergy 2005; 60: 1116–20
   PubMed Web of Science ®Google Scholar
• Holly EA, Lele C. Non-Hodgkin's lymphoma in HIV-positive and HIV-negative homosexual men in the San Francisco Bay Area: Allergies, prior medication use, and sexual practices. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15: 211–22
   PubMedGoogle Scholar
• Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol 2004; 113: 395–400
   PubMed Web of Science ®Google Scholar
• Melbye M, Trichopoulos D. Non-Hodgkin's Lymphomas. Textbook of Cancer Epidemiology1st ed, HO Adami, D Hunter, D Trichopoulos. Oxford University Press, New York 2002; 535–49
   Google Scholar
• Pearce, N, McLean, D. Agricultural exposures and non-Hodgkin's lymphoma. Scand J Work Environ Health 2005;31((Suppl 1)):18–25; discussion 15–17.
   PubMedGoogle Scholar
• Fritschi L, Benke G, Hughes AM, Kricker A, Turner J, Vajdic CM, et al. Occupational exposure to pesticides and risk of non-Hodgkin's lymphoma. Am J Epidemiol 2005; 162: 849–57
   PubMed Web of Science ®Google Scholar
• De Roos AJ, Hartge P, Lubin JH, Colt JS, Davis S, Cerhan JR, et al. Persistent organochlorine chemicals in plasma and risk of non-Hodgkin's lymphoma. Cancer Res 2005; 65: 11214–26
   PubMed Web of Science ®Google Scholar
• Garabrant DH, Philbert MA. Review of 2,4-dichlorophenoxyacetic acid (2,4-D) epidemiology and toxicology. Crit Rev Toxicol 2002; 32: 233–57
   PubMed Web of Science ®Google Scholar
• Nelson NJ. Studies examine whether persistent organic agents may be responsible for rise in lymphoma rates. J Natl Cancer Inst 2005; 97: 1490–1
   PubMedGoogle Scholar
• Pyatt D. Benzene and hematopoietic malignancies. Clin Occup Environ Med 2004; 4: 529–55
   PubMedGoogle Scholar
• Wartenberg D, Reyner D, Scott CS. Trichloroethylene and cancer: Epidemiologic evidence. Environ Health Perspect 2000; 108(Suppl 2)161–76
   PubMedGoogle Scholar
• Raaschou-Nielsen O, Hansen J, McLaughlin JK, Kolstad H, Christensen JM, Tarone RE, et al. Cancer risk among workers at Danish companies using trichloroethylene: A cohort study. Am J Epidemiol 2003; 158: 1182–92
   PubMed Web of Science ®Google Scholar
• Cancer I. A. f. R. o. Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. IARC monographs on the evaluation of carcinogenic risks in humans. Lyon France: 1997.
   Google Scholar
• Cole P, Trichopoulos D, Pastides H, Starr T, Mandel JS. Dioxin and cancer: A ritical review. Regul Toxicol Pharmacol 2003; 38: 378–88
   PubMed Web of Science ®Google Scholar
• Zahm SH, Weisenburger DD, Holmes FF, Cantor KP, Blair A. Tobacco and non-Hodgkin's lymphoma: combined analysis of three case-control studies (United States). Cancer Causes Control 1997; 8: 159–66
   PubMed Web of Science ®Google Scholar
• Adami J, Nyren O, Bergstrom R, Ekbom A, Engholm G, Englund A, et al. Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden). Cancer Causes Control 1998; 9: 49–56
   PubMed Web of Science ®Google Scholar
• Miligi L, Seniori Costantini A, Crosignani P, Fontana A, Masala G, Nanni O, et al. Occupational, environmental, and life-style factors associated with the risk of hematolymphopoietic malignancies in women. Am J Ind Med 1999; 36: 60–9
   PubMed Web of Science ®Google Scholar
• Willett EV, Smith AG, Dovey GJ, Morgan GJ, Parker J, Roman E. Tobacco and alcohol consumption and the risk of non-Hodgkin lymphoma. Cancer Causes Control 2004; 15: 771–80
   PubMed Web of Science ®Google Scholar
• Freedman DS, Tolbert PE, Coates R, Brann EA, Kjeldsberg CR. Relation of cigarette smoking to non-Hodgkin's lymphoma among middle-aged men. Am J Epidemiol 1998; 148: 833–41
   PubMed Web of Science ®Google Scholar
• Stagnaro E, Tumino R, Parodi S, Crosignani P, Fontana A, Masala G, et al. Non-Hodgkin's lymphoma and type of tobacco smoke. Cancer Epidemiol Biomarkers Prev 2004; 13: 431–7
   PubMed Web of Science ®Google Scholar
• Talamini, R, Polesel, J, Montella, M, Maso, LD, Crispo, A, Spina, M, et al. Smoking and non-Hodgkin lymphoma: Case-control study in Italy. Int J Cancer 2005. 115: 606–10
   PubMed Web of Science ®Google Scholar
• Morton LM, Holford TR, Leaderer B, Boyle P, Zahm SH, Zhang Y, et al. Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women. Br J Cancer 2003; 89: 2087–92
   PubMed Web of Science ®Google Scholar
• Schollkopf C, Smedby KE, Hjalgrim H, Rostgaard K, Gadeberg O, Roos G, et al. Cigarette smoking and risk of non-Hodgkin's lymphoma–a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2005; 14: 1791–6
   PubMed Web of Science ®Google Scholar
• Bell DA, Liu Y, Cortopassi GA. Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers. J Natl Cancer Inst 1995; 87: 223–4
   PubMed Web of Science ®Google Scholar
• Schroeder JC, Olshan AF, Baric R, Dent GA, Weinberg CR, Yount B, et al. A case-control study of tobacco use and other non-occupational risk factors for t(14;18) subtypes of non-Hodgkin's lymphoma (United States). Cancer Causes Control 2002; 13: 159–68
   PubMed Web of Science ®Google Scholar
• Chang ET, Smedby KE, Zhang SM, Hjalgrim H, Melbye M, Ost A, et al. Alcohol intake and risk of non-Hodgkin lymphoma in men and women. Cancer Causes Control 2004; 15: 1067–76
   PubMed Web of Science ®Google Scholar
• Morton LM, Zheng T, Holford TR, Holly EA, Chiu BC, Costantini AS, et al. Alcohol consumption and risk of non-Hodgkin lymphoma: A pooled analysis. Lancet Oncol 2005; 6: 469–76
   PubMed Web of Science ®Google Scholar
• Ward MH, Zahm SH, Weisenburger DD, Gridley G, Cantor KP, Saal RC, et al. Dietary factors and non-Hodgkin's lymphoma in Nebraska (United States). Cancer Causes Control 1994; 5: 422–32
   PubMed Web of Science ®Google Scholar
• Zheng T, Holford TR, Leaderer B, Zhang Y, Zahm SH, Flynn S, et al. Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in Connecticut women. Am J Epidemiol 2004; 159: 454–66
   PubMed Web of Science ®Google Scholar
• Chang ET, Smedby KE, Zhang SM, Hjalgrim H, Melbye M, Ost A, et al. Dietary factors and risk of non-hodgkin lymphoma in men and women. Cancer Epidemiol Biomarkers Prev 2005; 14: 512–20
   PubMed Web of Science ®Google Scholar
• Cerhan JR, Wallace RB, Folsom AR, Potter JD, Munger RG, Prineas RJ. Transfusion history and cancer risk in older women. Ann Intern Med 1993; 119: 8–15
   PubMed Web of Science ®Google Scholar
• Talamini R, Montella M, Crovatto M, Dal Maso L, Crispo A, Negri E, et al. Non-Hodgkin's lymphoma and hepatitis C virus: A case-control study from northern and southern Italy. Int J Cancer 2004; 110: 380–5
   PubMed Web of Science ®Google Scholar
• Zhang Y, Holford TR, Leaderer B, Boyle P, Zahm SH, Owens PH, et al. Blood transfusion and risk of non-Hodgkin's lymphoma in Connecticut women. Am J Epidemiol 2004; 160: 325–30
   PubMed Web of Science ®Google Scholar
• Chow EJ, Holly EA. Blood transfusions and non-Hodgkin's lymphoma. Epidemiol Rev 2002; 24: 269–79
   PubMed Web of Science ®Google Scholar
• Adami J, Nyren O, Bergstrom R, Ekbom A, McLaughlin JK, Hogman C, et al. Blood transfusion and non-Hodgkin lymphoma: Lack of association. Ann Intern Med 1997; 127: 365–71
   PubMedGoogle Scholar
• Kato I, Koenig KL, Shore RE, Baptiste MS, Lillquist PP, Frizzera G, et al. Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL) (United States). Cancer Causes Control 2002; 13: 965–74
   PubMed Web of Science ®Google Scholar
• Beiderbeck AB, Holly EA, Sturkenboom MC, Coebergh JW, Stricker BH, Leufkens HG. Prescription medications associated with a decreased risk of non-Hodgkin's lymphoma. Am J Epidemiol 2003; 157: 510–6
   PubMed Web of Science ®Google Scholar
• Beiderbeck AB, Holly EA, Sturkenboom MC, Coebergh JW, Stricker BH, Leufkens HG. No increased risk of non-Hodgkin's lymphoma with steroids, estrogens and psychotropics (Netherlands). Cancer Causes Control 2003; 14: 639–44
   PubMed Web of Science ®Google Scholar
• Chang ET, Smedby KE, Hjalgrim H, Schollkopf C, Porwit-MacDonald A, Sundstrom C, et al. Medication use and risk of non-Hodgkin's lymphoma. Am J Epidemiol 2005; 162: 965–74
   PubMed Web of Science ®Google Scholar
• James PT. Obesity: The worldwide epidemic. Clin Dermatol 2004; 22: 276–80
   PubMed Web of Science ®Google Scholar
• Skibola CF, Holly EA, Forrest MS, Hubbard A, Bracci PM, Skibola DR, et al. Body mass index, leptin and leptin receptor polymorphisms, and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2004; 13: 779–86
   PubMed Web of Science ®Google Scholar
• Moller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: A Danish record-linkage study. Eur J Cancer 1994; 30A: 344–50
   PubMed Web of Science ®Google Scholar
• Zhang S, Hunter DJ, Rosner BA, Colditz GA, Fuchs CS, Speizer FE, et al. Dietary fat and protein in relation to risk of non-Hodgkin's lymphoma among women. J Natl Cancer Inst 1999; 91: 1751–8
   PubMed Web of Science ®Google Scholar
• Chang ET, Hjalgrim H, Smedby KE, Akerman M, Tani E, Johnsen HE, et al. Body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst 2005; 97: 210–8
   PubMed Web of Science ®Google Scholar
• Cerhan JR, Janney CA, Vachon CM, Habermann TM, Kay NE, Potter JD, et al. Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: A prospective study. Am J Epidemiol 2002; 156: 527–35
   PubMed Web of Science ®Google Scholar
• Correa A, Jackson L, Mohan A, Perry H, Helzlsouer K. Use of hair dyes, hematopoietic neoplasms, and lymphomas: A literature review. II. Lymphomas and multiple myeloma. Cancer Invest 2000; 18: 467–79
   PubMed Web of Science ®Google Scholar
• Tavani A, Negri E, Franceschi S, Talamini R, Serraino D, La Vecchia C. Hair dye use and risk of lymphoid neoplasms and soft tissue sarcomas. Int J Cancer 2005; 113: 629–31
   PubMed Web of Science ®Google Scholar
• Zhang Y, Holford TR, Leaderer B, Boyle P, Zahm SH, Flynn S, et al. Hair-coloring product use and risk of non-Hodgkin's lymphoma: A population-based case-control study in Connecticut. Am J Epidemiol 2004; 159: 148–54
   PubMed Web of Science ®Google Scholar
• Adami HO, Tsaih S, Lambe M, Hsieh C, Adami J, Trichopoulos D, et al. Pregnancy and risk of non-Hodgkin's lymphoma: A prospective study. Int J Cancer 1997; 70: 155–8
   PubMedGoogle Scholar
• Zhang Y, Holford TR, Leaderer B, Boyle P, Zahm SH, Zhang B, et al. Menstrual and reproductive factors and risk of non-Hodgkin's lymphoma among Connecticut women. Am J Epidemiol 2004; 160: 766–73
   PubMedGoogle Scholar
• Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol 2004; 5: 617–25
   PubMed Web of Science ®Google Scholar
• Bryla CM. The relationship between stress and the development of breast cancer: A literature review. Oncol Nurs Forum 1996; 23: 441–8
   PubMedGoogle Scholar
• d'Amore FCB, Brincker H, Pedersen NT, Thorling K, Hastrup J, Pedersen MJM, Johansen P, Andersen E. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. Eur J Cancer 1991; 27: 1201–08
   PubMed Web of Science ®Google Scholar